Trademark: 79266160
Status Date
Friday, October 1, 2021
Filing Date
Friday, July 19, 2019
Abandoned Date
Wednesday, September 29, 2021
5 Cellular function activating agents for medical purposes; therapeutic pharmaceutical for the treatment of wounds, skin conditions, orthopaedic conditions including sarcopenia, osteoarthritis and tendinopathy, degenerative eye disease including age related macular degeneration, age related conditions, neurodegenerative disease, depression, bleeding, trauma, stroke, heart disease
Jul 18, 2021
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Jul 17, 2021
Death Of International Registration
Feb 22, 2021
Notification Of Possible Opposition - Processed By Ib
Feb 8, 2021
Report Completed Suspension Check Case Still Suspended
Feb 3, 2021
Notification Of Possible Opposition Sent To Ib
Feb 3, 2021
Notification Of Possible Opposition Created, To Be Sent To Ib
Dec 18, 2020
Change Of Name/Address Rec'd From Ib
Jun 26, 2020
Report Completed Suspension Check Case Still Suspended
Jun 25, 2020
Assigned To Lie
May 26, 2020
Assigned To Examiner
Dec 20, 2019
Refusal Processed By Ib
Nov 26, 2019
Non-Final Action Mailed - Refusal Sent To Ib
Nov 26, 2019
Refusal Processed By Mpu
Nov 5, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Nov 4, 2019
Suspension Letter Written
Oct 30, 2019
Non-Final Action (Ib Refusal) Withdrawn For Review
Oct 10, 2019
Non-Final Action (Ib Refusal) Prepared For Review
Oct 9, 2019
Suspension Letter Written
Oct 4, 2019
Assigned To Examiner
Sep 13, 2019
Application Filing Receipt Mailed
Sep 9, 2019
New Application Office Supplied Data Entered In Tram
Aug 29, 2019
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
